Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Clinical Cardiology|July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM studyFabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.Resuscitation|June 26, 2024
Heart rate variability for neuro-prognostication after CA: Insight from the Parisian registrySarah Benghanem, Tarek Sharshar, Martine Gavaret, et al.International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.Acta Cardiologica|September 29, 2017
Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarctionQuentin de Hemptinne, Fabien Picard, Hung Q Ly, et al.Archives of Cardiovascular Diseases|February 16, 2023
Initiation and development of a percutaneous left atrial appendage closure programme: A French centre's experience and literature reviewEmeric Albert, Tania Puscas, Gabriel Seret, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 5, 2018
Clinical outcomes of bioresorbable vascular scaffold to treat all-comer patients. Are patients with acute coronary syndrome better candidates for bioresorbable vascular scaffold?Fabien Picard, Robert Avram, Guillaume Marquis-Gravel, et al.Cells|April 5, 2020
Looking at New Unexpected Disease Targets in <i>LMNA</i>-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical PracticeHéléna Mosbah, Camille Vatier, Franck Boccara, et al.Circulation. Cardiovascular Interventions|October 22, 2016
Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions)Lorenzo Azzalini, Gennaro Giustino, Soledad Ojeda, et al.Journal of Interventional Cardiology|December 21, 2023
In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery DiseaseQuentin Landolff, Marine Quillot, Fabien Picard, et al.European Heart Journal. Acute Cardiovascular Care|February 21, 2024
In-hospital prognosis of acute ST-elevation myocardial infarction in patients with recent recreational drug useArthur Clement, Jean-Guillaume Dillinger, Arthur Ramonatxo, et al.Pageof 8